Roche Holding AG expects to have reimbursement for blockbuster eye drug Vabysmo in the top five European markets by the end of the year, broadening the reach of its fastest growing product.
Roche is wrapping up negotiations with payers in Italy, France and Spain and expects to have national reimbursement this year in all three countries, the company said. The eye injection is already widely available in the UK and Germany. Vabysmo won European marketing authorization in September of last year, but coverage via public insurance in continental countries generally requires an agreement about pricing.
Roche still aims to hit $2 billion in sales for Vabysmo this year, said Nilesh Mehta, the Basel-based drugmaker’s franchise head for ophthalmology. It’s a key part of Roche’s strategy for compensating the loss of its pandemic-era windfalls on the sale of Covid-19 tests and treatments. Already widely used in the US, the eye drug is also starting to see “really strong uptake” in other countries, Mehta said in an interview. He cited Switzerland and the UK, where drug advisory board NICE signed off on the product a week after approval there in May. “This really demonstrates to us that even in a situation where cost effectiveness is demanded of a product, they’re seeing the value of Vabysmo,” he said.
Roche declined to comment on the drug’s price in the UK. In Germany, generally Europe’s most expensive market for drugs, Vabysmo has a list price of €1,136.52 per vial, about 40% below the US list price.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
B.C. wildfires: Fire still growing in Shuswap area, firefighting gear being stolenA huge problem for BC Wildfire Service crews in the North Shuswap area is that their gear is being stolen.
Read more »
Dollar gains intact as traders eye Jackson HoleBy Tom Westbrook SINGAPORE (Reuters) - The dollar began on a firm footing on Monday, following five straight weeks of gains, as investors looked ahead ...
Read more »
Dollar gains intact as China disappoints, traders eye Jackson HoleBy Tom Westbrook SINGAPORE (Reuters) - The dollar began on a firm footing on Monday, following five straight weeks of gains, as investors looked ahead ...
Read more »
China surprises with modest rate cut amid growing yuan risksSHANGHAI/SINGAPORE (Reuters) -China cut its one-year benchmark lending rate on Monday as authorities seek to ramp up efforts to stimulate credit demand, ...
Read more »
China surprises with modest rate cut amid growing concerns about rapidly weakening yuanChina’s economic recovery has lost steam due to a worsening property slump, weak consumer spending and tumbling credit growth, adding to the case for authorities to release more policy stimulus
Read more »
David Rosenberg: The Great China slowdown has wider implications than meets the eyeChina\u0027s economic slump is more complex and has wide\u002Dranging implications than meets the eye. Read more from David Rosenberg
Read more »